Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

Related Articles by Review for PubMed (Select 20413348)

1.

Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism.

Relling MV, Altman RB, Goetz MP, Evans WE.

Lancet Oncol. 2010 Jun;11(6):507-9. doi: 10.1016/S1470-2045(10)70097-8. Epub 2010 Apr 21. No abstract available. Erratum in: Lancet Oncol. 2010 Jun;11(6):516.

PMID:
20413348
2.

Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies.

Kiyotani K, Mushiroda T, Zembutsu H, Nakamura Y.

J Hum Genet. 2013 Jun;58(6):327-33. doi: 10.1038/jhg.2013.39. Epub 2013 May 9. Review.

PMID:
23657426
3.

[Pharmacogenetics].

Hach I, Kirch W.

Praxis (Bern 1994). 2008 Oct 22;97(21):1127-9. doi: 10.1024/1661-8157.97.21.1127. Review. German. No abstract available.

PMID:
18951351
4.

Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance.

Teh LK, Bertilsson L.

Drug Metab Pharmacokinet. 2012;27(1):55-67. Epub 2011 Dec 20. Review.

5.

Pharmacogenetic screening and therapeutic drugs.

Steimer W, Potter JM.

Clin Chim Acta. 2002 Jan;315(1-2):137-55. Review.

PMID:
11728416
6.

The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.

Fleeman N, Martin Saborido C, Payne K, Boland A, Dickson R, Dundar Y, Fernández Santander A, Howell S, Newman W, Oyee J, Walley T.

Health Technol Assess. 2011 Sep;15(33):1-102. doi: 10.3310/hta15330. Review.

7.

[Thiopurine methyltransferase (TPMP) polymorphism: a model of clinical application for pharmacogenetics].

Kurzawski M, Droździk M.

Pol Arch Med Wewn. 2003 May;109(5):535-40. Review. Polish. No abstract available.

PMID:
14768185
8.

Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?

Higgins MJ, Rae JM, Flockhart DA, Hayes DF, Stearns V.

J Natl Compr Canc Netw. 2009 Feb;7(2):203-13. Review.

PMID:
19200418
9.

Pharmacogenomics of endocrine therapy in breast cancer.

Weinshilboum R.

Adv Exp Med Biol. 2008;630:220-31. Review.

PMID:
18637494
10.

Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.

Pui CH, Relling MV, Evans WE.

Best Pract Res Clin Haematol. 2002 Dec;15(4):741-56. Review.

PMID:
12617874
11.

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, Ellingrod VL, Skaar TC, Müller DJ, Gaedigk A, Stingl JC; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2013 May;93(5):402-8. doi: 10.1038/clpt.2013.2. Epub 2013 Jan 16. Review.

12.

Pharmacogenomics of pediatric acute lymphoblastic leukemia.

Meeker ND, Yang JJ, Schiffman JD.

Expert Opin Pharmacother. 2010 Jul;11(10):1621-32. doi: 10.1517/14656566.2010.484019. Review.

PMID:
20429672
13.

Pharmacogenomics of tamoxifen and irinotecan therapies.

Algeciras-Schimnich A, O'Kane DJ, Snozek CL.

Clin Lab Med. 2008 Dec;28(4):553-67. doi: 10.1016/j.cll.2008.05.004. Review.

PMID:
19059062
14.

Pharmacogenetics of breast cancer therapies.

Hertz DL, McLeod HL, Hoskins JM.

Breast. 2009 Oct;18 Suppl 3:S59-63. doi: 10.1016/S0960-9776(09)70275-9. Review.

PMID:
19914545
15.

[Genetic polymorphism of CYP-450 in drug development].

Nonen S, Azuma J.

Nihon Yakurigaku Zasshi. 2009 Oct;134(4):212-5. Review. Japanese. No abstract available.

PMID:
19828926
16.

Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?

Stearns V, Rae JM.

Expert Rev Mol Med. 2008 Nov 20;10:e34. doi: 10.1017/S1462399408000896. Review.

17.

Acute lymphoblastic leukemia.

Pui CH, Relling MV, Downing JR.

N Engl J Med. 2004 Apr 8;350(15):1535-48. Review. No abstract available.

PMID:
15071128
18.
19.

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

Cheok MH, Evans WE.

Nat Rev Cancer. 2006 Feb;6(2):117-29. Review. Erratum in: Nat Rev Cancer. 2006 Mar;6(3):249.

PMID:
16491071
20.

Tamoxifen and CYP2D6: a contradiction of data.

Hertz DL, McLeod HL, Irvin WJ Jr.

Oncologist. 2012;17(5):620-30. doi: 10.1634/theoncologist.2011-0418. Epub 2012 Apr 24. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk